Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.15% while the Hang Seng is up 0.66%. The Shanghai Composite is trading up by 0.52%. US stocks ended in green on Wednesday, with gains in real estate and utilities offsetting declines in energy and telecommunications stocks.
Tata steel share price opened the day on an encouraging note on the reports that the company has appointed a domestic investment bank to manage its proposed rights issue of about US$2bn (Rs 128 bn). The stated purpose of the rights issue is to deleverage the firm.
The injections to be marketed will be in the strengths of 2.5 mg/0.5 mL, 5 mg/0.4 mL, 7.5 mg/0.6 mL, and 10 mg/0.8 mL single-dose prefilled syringes. It is used to prevent deep vein thrombosis (DVT).
Reportedly, the approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug (RLD) product Arixtra Injection of Mylan Ireland. The product will be launched in January 2018.
